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Research Article
Comparative analysis of the full set
of methylated -cyclodextrins as chiral
selectors in capillary electrophoresis
The chiral separation ability of the full library of methylated--cyclodextrins towards phar-
macologically significant racemic drugs including basic compounds was studied by chiral
CE. The syntheses of all the methylated, single isomer -cyclodextrins were revised and
optimized and the aqueous solubility of the derivatives was unambiguously established.
The three most relevant commercially available methylated isomeric mixtures were also
included in the screening, so a total of ten various methylated CDs were investigated.
The effects of the selector concentration on the enantiorecognition properties at acidic
pH were investigated. Among the dimethylated -cyclodextrins, the heptakis (2,6-di-O-
methyl)--cyclodextrin isomer (2,6-DIMEB) resulted to be themost versatile chiral selector.
Terbutaline was selected as amodel compound for the in-depth investigation of host-guest
enantiodiscrimination ability. The association constants between the two terbutaline enan-
tiomers and 2,6-DIMEB were determined in order to support that the enantioseparation
is driven by differences is host-guest binding. The migration order of the enantiomers
was confirmed by performing spiking experiments with the pure enantiomers. 1D and
2D NMR spectroscopy was applied to the 2,3-, and 2,6-DIMEB/terbutaline systems to
rationalize at molecular level the different enantioseparation ability of the dimethylated
-cyclodextrin selectors.
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in; 3,6-DIMEB, heptakis (3,6-di-O-methyl)--cyclodextrin; 2-
MEB, heptakis (2-O-methyl)--cyclodextrin; 3-MEB, heptakis
(3-O-methyl)--cyclodextrin; 6-MEB, heptakis (6-O-methyl)-
-cyclodextrin; BCD, -cyclodextrin; CCE, chiral capillary
electrophoresis; CRYSMEB R©, crystalline methylated-
-cyclodextrin; DIMEB50, heptakis (2,6-di-O-methyl)--
cyclodextrin  35%; DMSO, dimethyl sulfoxide; DS, degree
of substitution; HDMCM, heptakis(2,3-di-O-methyl-6-O-
carboxymethyl); KOH, potassium hydroxide; Pd/C, palla-
dium on activated charcoal; PTC, phase-transfer catalysis;
RAMEB R©, randomly methylated--cyclodextrin; ROESY,
rotating frame nuclear Overhauser effect spectroscopy;
TBAF, tetrabutylammonium fluoride; THF, tetrahydrofuran;
TRIMEB, heptakis (2,3,6-tri-O-methyl)--cyclodextrin)
1 Introduction
Chiral capillary electrophoresis (CCE) has been applied fre-
quently as a simple and reliable analytical technique inmainly
pharmaceutical analysis [1–3]. Having its major advantages
(such as the high plate numbers, the consumption of minute
amounts of aqueous solutions, the straightforward method
development in short time, the capability of high through-
put, i.e. fast screening setup, and the possibility of the re-
versal of the migration order, etc.) over the most commonly
used LC methods makes CCE very popular in analytical scale
enantioseparations. Despite all these, CCE is usually not the
first choice in case analysts face enantiomeric purity determi-
nation challenges. Unfortunately, CCE methods are rather
underrepresented in pharmacopoeial monographs as well. It
has been argued that general methods describing the enan-
tioseparation have to be more elaborated in order to add
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irrefutable data about the paramount importance of CCE in
separation science. More than 10 years ago, Holzgrabe pre-
sented that CCE has superiority over LC in many of the cases
and emphasized that a careful and valid experimental proce-
dure results in a competitive CCEmethod [4]. In recent years,
there is still a growing number of CCE methods published,
in which CCE has been supported by NMR and/or molecular
modeling to provide a solid background of the enantiosepa-
ration at the molecular level.
CDs arewater-soluble cyclic oligosaccharides, shaped like
a truncated cone, with a central hydrophobic cavity. These
sugars have been extensively utilized as excipients in phar-
maceutical and food industry [5], and due to their specific
3D arrangement and inherent chirality, they have been used
as analytical tools for enantioseparation, especially as chi-
ral selectors (i.e. BGE additives) in CCE [6, 7]. However, the
selection of the appropriate chiral selector for CCE is still
challenging. It is still not well predictable how the chosen se-
lectors will perform under given conditions using the analyte
in question.
Recently, there are countless semisynthetic CD deriva-
tives with various substituents (bearing fit-for purpose
functionalities in the introduced sidechains); however, their
wide applicability can mostly be rationalized by their ease of
availability. The application of native, unmodified CDs has
certain advantages being available at a low prize, but among
the limitations – especially for that of the most commonly
applied -cyclodextrin (BCD) – one can mention its relatively
low aqueous solubility. This drawback hampers its use where
higher selector concentrations are necessary for achieving the
required selectivity. To overcome the solubility issues, differ-
ent synthetic methodologies were developed for the chemical
derivatization of BCD [8]. Random functionalization pro-
cesses with methylating agents result in ill-defined mixtures,
but these processes are usually up-scalable, making possible
the industrial application of these derivatives. Methylated
CDs are one of themost effective solubilizers of poorly soluble
organic compounds [9–11], but also frequently used as chiral
selectors [12–15]. Selectively methylated BCDs, also called
single-isomer methyl-CDs derivatives have been prepared
through multistep reactions (heptakis (2,3,6-tri-O-methyl)--
cyclodextrin [TRIMEB]), through repeated chromatographic
and crystallization cycles (heptakis (2,6-di-O-methyl)--
cyclodextrin [2,6-DIMEB]) or through exhaustive use of
protecting groups (heptakis (3,6-di-O-methyl)--cyclodextrin
[3,6-DIMEB] for example) and applied mainly in separation
sciences and in chemosensing. Although methylated CDs
are used in diverse applications, their detailed structural
characterization is still challenging [16, 17]. The degree and
the site of methylation influences the properties such as
solubility, complexation ability, and enantiorecognition of
the CD, therefore it is of vital importance to gain as complete
picture as possible on these features. The enantiorecognition
ability of various methylated CDs has already been investi-
gated previously; however, those studies did not cover the
full set of the available CDs or did not use single chemical
entities but mixtures of variously under-/over-methylated
isomers [18–20]. The effect of degree of methylation on
the enantiomer migration order has also been shown for
peptide enantiomers reviewed by G.K.E Scriba [21]. It has
been recently shown, that the degree of methylation can also
affect the enantiomer migration order as well [22].
CE in conjunction with NMR spectroscopy can provide
valuable information regarding the structure and selector-
selectand complexes, therefore appointing the moieties re-
sponsible for enantiodiscrimination [23–26]. In our study,
all the single isomer per-monomethylated, per-dimethylated,
and the commercially available randomly substituted CDs
along with the per-trimethylated derivative were screened us-
ing a set of racemic compounds in CCE to establish structure-
enantiodiscrimination relationships. To get an atomic level
picture on the enantiorecognition, a commonly used model
drug terbutaline was chosen [12, 27–29].
2 Materials and methods
2.1 Chemicals and materials
The BCD was the product of Wacker Chemie AG (Mu¨nchen,
Germany); randomly methylated--cyclodextrin (RAMEB R©;
CAVASOL R© W7 M), crystalline methylated--cyclodextrin
(CRYSMEB R©), heptakis (2,6-di-O-methyl)--cyclodextrin
 35% (DIMEB50; 2,6-DIMEB content 35%)were products
of Wacker, Roquette and CycloLab, respectively. Syntheses
solvents such as pyridine (Pyr), tetrahydrofuran (THF),
methanol (MeOH), acetone (ACE), N,N-dimethylformamide
(DMF), dimethyl sulfoxide (DMSO) were of reagent grade
and were sourced from Molar Chemicals (Hala´sztelek,
Hungary); methyltriphenylphosphonium bromide (98%),
benzyl bromide (Bn-Br, 98%), lithium iodide (anhydrous,
beads, 10 mesh, 99.99% trace metals basis), lithium hy-
dride (powder, 30 mesh, 95%), (4-(dimethylamino)pyridine
(DMAP, 99%), tetrabutylammonium fluoride (TBAF,
98%), ammonium hydrogen difluoride (99%), palladium on
activated charcoal (Pd/C, 10%), potassium hydroxide (KOH,
85%), tert-butyldimethylsilyl chloride (TBDMSi-Cl, 97%),
methyl iodide (ReagentPlus R©, 99%), hydrazine carbonate
(70% in water, ca. 7.3 M), deuterium oxide (D2O, 99.9%
atom % D), chloroform-d (CDCl3,99.8 atom % D), dimethyl
sulfoxide-d6(DMSO-d6, 99.96 atom % D) were sourced from
Sigma Aldrich (St. Louis, MO, USA).
Most of the studied racemates such as tapentadol, oc-
topamine, carvedilol, verapamil,methylenedioxipyrovalerone
(MDPV), 4-methylethcathinone (4-MEC), flephedrone (4-
FMC), mephedrone (4-MMC), butylone (k-MBDB),
vincamine, vincadifformine, vinpocetine, primaquine,
tafenoquine, mefloquine, propranolol, bisoprolol, pindolol,
atenolol, pantoprazole, ketoconazole, chlorpheniramine,
cetirizine, and metoprolol were purchased from commercial
suppliers and were of analytical/pharmaceutical grade.
Racemic dapoxetine and alogliptin were synthesized as
described previously [14, 30]. Terbutaline enantiomers were
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Figure 1. Cartoon representations of methylated -cyclodextrin derivatives.
isolated and kindly provided by Prof. B. Chankvetadze
according to their recent publication [28].
2.2 Syntheses of methylated CDs
Figure 1 shows the cartoon representations of the complete
set of methylated -CDs utilized in this study.
The detailed descriptions of the procedures, the synthetic
schemes with atoms-numbered structures and NMR data are
shown in the Supporting Information. TRIMEB was pre-
pared by exhaustive methylation of RAMEB R© under phase-
transfer catalysis (PTC) conditions in THF by using methyl
iodide as alkylating agent, KOH as base, and triphenylmethyl-
phosphonium bromide.
Heptakis (2,3-di-O-methyl)--cyclodextrin (2,3-DIMEB)
was prepared in three synthetic steps. Native BCD was re-
gioselectively functionalized on primary hydroxyl groupswith
TBDMSi-Cl in pyridine, then completemethylation of the sec-
ondary side was achieved under phase-transfer catalysis con-
ditions and mild removal of primary-side protecting groups
with ammonium bifluoride in methanol yielding the titled
compound [31].
2,6-DIMEB was obtained by recrystallizion of DIMEB50
in hot acetone, hot methanol, and by cromatography on silica
with acetone as eluent in isocratic elution.
3,6-DIMEB was prepared in five steps according to a
variation of the procedure described by Stoddart [32]. The
benzylation of heptakis(2,6-di-O-tert-butyldimethylsilyl)-BCD
was accomplished under PTC conditions in THF with KOH
as base, benzyl bromide as alkylating agent and triphenyl-
methylphosphonium bromide as catalyst. The conversion
to heptakis(2-O-benzyl-3,6-di-O-tert-butyldimethylsilyl)-BCD
is exhaustive at room temperature and does not require
purification by chromatography. Removal of silyl groups
was achieved in THF at room temperature with TBAF
while methylation was performed under PTC conditions in
THF with KOH as base, methyl iodide as alkylating agent,
and triphenylmethylphosphonium bromide as catalyst.
The final cleavage of the benzyl groups was obtained by
hydrazine-mediated transfer-hydrogenation.
Heptakis (2-O-methyl)--cyclodextrin (2-MEB) was
prepared according to a variation of the procedure described
by Stoddart [32]. The methylation of heptakis(2,6-di-O-
tert-butyldimethylsilyl)-BCD was accomplished under PTC
conditions in THF with KOH as base, methyl iodide as alky-
lating agent, and triphenylmethylphosphonium bromide as
catalyst. The conversion to heptakis(2-O-methyl-3,6-di-O-tert-
butyldimethylsilyl)-BCD is exhaustive at room temperature
and does not require purification by chromatography. The
final removal of silyl groups was achieved in THF at room
temperature with TBAF.
Heptakis (3-O-methyl)--cyclodextrin (3-MEB) was pre-
pared in a five-step synthesis. The primary side of the BCD
was protected with TBDMSi-Cl in pyridine. Regioselective
per-2-O-benzylation was achieved in DMSO with lithium hy-
dride, benzyl bromide, and lithium iodide as catalyst. Hep-
takis (2-O-benzyl-6-O-methyl)-BCD was obtained after purifi-
cation by chromatography with hexane: EtOAc 9:1 as eluent
in isocratic elution. Exhaustive 3-O-methylation was achieved
under PTC conditions (THF as solvent, potassium hydrox-
ide as base, methyl-iodide as alkylating agent, and triphenyl-
methylphosphonium bromide as catalyst). Deprotection of
the primary-side was accomplished with TBAF at room tem-
perature overnight in THF. Debenzylation of the secondary-
sidewas attained by applying hydrazine-carbonate in the pres-
ence of Pd/C.
Heptakis (6-O-methyl)--cyclodextrin (6-MEB) was pre-
pared according to a five-step synthesis. The primary hy-
droxyl groups of the native BCD were selectively protected
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with TBDMSi-Cl in pyridine. Benzylation of the secondary
side was achieved by PTC (THF was used as solvent, KOH
as base, benzyl bromide as alkylating agent and triphenyl-
methylphosphonium bromide as catalyst) under mild condi-
tions without the need of rigorous dry environment. The reac-
tion crude was purified by simple precipitation with excellent
yields. Deprotection of the primary-side (O-desilylation) was
exhaustively accomplished with excess of (harmless) TBAF
at room temperature overnight in THF. Per-6-O-methylation
of the CD ring was also achieved by PTC with methyl io-
dide. The removal of benzyl moieties, used as temporary
secondary-side protecting groups, was attained by applying
hydrazine-carbonate in the presence of Pd/C.
2.3 Instrumentations and methods
CE measurements were carried out on an Agilent 7100
instrument (Agilent Technologies, Waldbronn, Germany),
equipped with a photodiode array detector (DAD) and the
Chemstation software for data handling.Measurements were
performed in untreated fused silica capillaries (33.5 cm total
and 25 cm effective length and 50 µm id) purchased from
Agilent Technologies. Prior to all runs, the capillary was pre-
conditioned by rinsing with 0.1 M NaOH (2 min), water
(2 min), and the appropriate BGE (3 min). The tempera-
ture of the capillary was set to 20°C. During measurements
20 kV was applied, UV detection was performed at 200 nm.
Samples were injected hydrodynamically (40 mbar × 3 sec).
The running buffer was 20 mM phosphoric acid (85%) ad-
justed to pH 2.5 with 1 M NaOH. The BGE contained the
appropriate methylated-BCDs at 1, 2.5, and 5 mM concentra-
tions for the less soluble 2-MEB and 6-MEB, and 10, 20, and
30 mM for 2,3-DIMEB, 3,6-DIMEB, 2,6-DIMEB, DIMEB50,
CRYSMEB R©, RAMEB R©, and TRIMEB. Stock solutions of the
investigated analytes were prepared at 1 mg/mL concentra-
tion in methanol and their 50-fold dilution with water was
used to prepare working solutions for CE analysis.
The enantioresolution (RS) values were calculated with
the formula:
RS = 2
(tr − ts)
wr + ws (1)
where tr and ts are the migration times of the enantiomers
and wr and ws stand for the extrapolated peak widths at the
baseline.
For the determination of enantiomer migration order
in case of terbutaline, MeOH stock solutions of S-(+)-
terbutaline (1 mg/mL) and R-(-)-terbutaline (1 mg/mL) were
prepared.R-(-)-terbutaline stock solutionwas diluted with wa-
ter 50-fold, while S-(+)-terbutaline stock solution was diluted
25-fold with water to obtain work solutions. These work so-
lutions were mixed to obtain the work solution ‘terbutaline
spiked’ in which the concentration of S-(+)-terbutaline was
doubled with respect to R-(-)-terbutaline.
For the determination of association constants, the
racemic terbutaline sample was prepared by 50-fold dilu-
tion of the methanol stock solution with water containing
0.1 v/v% DMSO serving as EOF marker. The experiment
was carried out by running the sample in BGEs containing
increasing concentration of 2,6-DIMEB (0–10–15–20–25–30–
35–40 mM). The basic principle of this set up is the assump-
tion that the presence of the CD selector affects the migra-
tion velocity of the guest in case the complexation takes place
(Note: in the current system, the selector is neutral, while
the guest is positively charged, therefore increasing concen-
tration of the host results in decreasing the mobility of the
guests, thereby upon complexation terbutaline enantiomers
migrate slower). Obviously, according to changes in the BGE
(e.g. increase in viscosity due to 2,6-DIMEB addition), the
migration time of the neutral species may change as well.
By relating the migration time of the guests to that of the
EOF, these effects are compensated during the calculations.
In general, the more stable complex is formed with the host,
themoremigration time of the free guest is influenced. From
the dataset of migration times and selector concentrations,
the stability constant can be determined with the x-reciprocal
method [15, 23, 33, 34]. Although this is a simple and still
routinely used method in the case of fast screening experi-
ments, evaluations with non-linear fittings provide more re-
liable data and also complex mobility values. The effective
electrophoretic mobility (eff) can be obtained from:
e f f =
l c l d
U
·
(
1
t
− 1
t0
)
(2)
where lc is the total length of the capillary, ld is the length of
the capillary to the detector, U is the applied voltage, while t
and t0 are the peak appearance times of the analyte and the
EOF marker, respectively.
To obtain the cyclodextrin-terbutalin binding constants,
the experimental eff versus cCD dataset has to be fitted by
the following function:
eff = free + cplxK
[CD]
1 + K [CD] (3)
wherefree is themobility of terbutaline in the absence of CD,
cplx and K are the electrophoretic mobility and the binding
constant of the terbutaline–CD complex, respectively.
All NMR experiments were carried out on a 600 MHz
Varian NMR spectrometer (using a DirectDigital Receiver)
equipped with a 5 mm inverse-detection gradient (IDPFG)
probehead. For structural characterization of the synthesis in-
termediates and final CD products, standard pulse sequences
and processing routines available in VnmrJ 3.2 C/Chempack
5.1 were used. The complete resonance assignments were
established from direct 1H–13C, long-range 1H–13C, and
scalar spin–spin connectivities derived from 1D 1H, 13C, 1H–
1H gCOSY, 1H–13C gHSQCAD, 1H–13C gHMBCAD experi-
ments, respectively. The probe temperature was maintained
at 298 K and standard 5 mm NMR tubes were used. The 1H
chemical shiftswere referenced to the appliedNMRsolvent in
each case. The detailed NMR study of racemic terbutaline and
2,6-DIMEB was performed in D2O under acidic condi-
tions. Appropriate amount of racemic terbutaline HCl and
2,6-DIMEB were dissolved to obtain a 1:1.5 molar ratio
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(2:3 mM). The individual resonances of terbutaline were
assigned by spiking the solution with single enantiomer
terbutaline. Spatial proximities were deduced from two-
dimensional rotating frame nuclear Overhauser effect spec-
troscopy (2D ROESY) experiment (using a mixing time value
of 300 msec) with standard experimental setup used in
Chempack.
3 Results and discussion
3.1 Enantioseparation by CE
The three representatives of the methylated mixture of iso-
mers, RAMEB R©, CRYSMEB R©, and DIMEB50 are materials
with rather different compositions and properties. RAMEB R©
is a mixture of randomly methylated isomers with an average
degree of substitution (DS) around 12 with high aqueous sol-
ubility (see Supporting Information Table 1 for the data about
the aqueous solubilities of all the methylated CDs). The pat-
tern of substitution of the isomeric populations is almost
statistical (the three O-methyl signals in the 1H-NMR spec-
trum corresponding to 2-O-, 3-O-, and 6-O-substitution are
1:1:1). CRYSMEB R© is a mixture of methylated isomer with
low DS (around 4) and the isomers composing the material
are mainly (if not exclusively) substituted on the secondary
side (i.e., 2-O- and 3-O-substituted). The material is more
soluble in water than native BCD, but its aqueous solubility
is not pronounced. DIMEB50 is a mixture of (di)methylated
isomers with a DS of 15–16. The main component of the
mixture is the 2,6-DIMEB (around 35% based on our in-house
CycloLab HPLC method) and the material has a very high
aqueous solubility.
Among the three selected randomly methylated com-
posite products and under the tested experimental condi-
tions, the best performing methylated mixture of isomers
was DIMEB50. The product first prepared in industrial scale
by Chinoin (Hungary) allowed to separate 12 out of the 27
pairs of screened racemates. RAMEB R© and CRYSMEB R© per-
formed efficiently as versatile chiral selectors as well, taken
into accounts that ten and nine pairs of stereoisomers were
successfully separated, respectively. In more detail, tapenta-
dol, carvedilol, flephedrone, vinpocetine, mefloquine, panto-
prazole, and terbutaline were at least partially separated by all
the three methylated composite materials (see Table 1 for all
the Rs values).
DIMEB50 performed best with flephedrone (Rs = 1.18
at 3.3 mM), mefloquine (Rs diast = 4.69 at 10 mM), and terbu-
taline (Rs = 2.16 at 10 mM), RAMEB R© was superior in re-
solving tapentadol (Rs diast = 4.32 at 10 mM) and vinpocetine
(Rs diast = 3.4 at 30 mM, see Fig. 2), while CRYSMEB R© could
effectively separate carvedilol (Rs = 1.13 at 10 mM). Pan-
toprazole was equally resolved by all the three methylated
composite materials (Rs = 0.46 at 10 mM).
Among the random methylated materials, DIMEB50
was the only selector able to provide partial resolution for
mephedrone (Rs = 0.42 at 20 mM) and butylone (Rs = 0.4 at
10mM), CRYSMEB R© uniquely allowed separation forMDPV
(Rs = 0.35 at 10mM),whileRAMEB R© permitted partial seper-
ation of propranolol (Rs = 0.21 at 10 mM). Octopamine and
pindolol were partially resolved by RAMEB R© (Rs = 0.6 and
Rs = 0.4 at 30 mM, respectively), DIMEB50 (Rs = 0.91 and
Rs = 0.43 at 30 mM, respectively), 2,6-DIMEB (Rs = 0.88 and
Rs = 0.43 at 30 mM), while CRYSMEB R© was ineffective for
these racemic mixtures, a high DS of methylation seems nec-
essary for the enantioseparation of these drugs. The case of ke-
toconazole is more difficult to rationalize: enantioseparation
was achieved effectively with DIMEB50 (Rs = 1.67 at 30 mM)
and CRYSMEB R© (Rs = 1.6 at 30 mM), while RAMEB R©
was an inefficient additive in this case. The enantiomers of
this antifungal medication could also be resolved by using
TRIMEB (which provided the best resolution among all tested
methylated derivatives, Rs = 3.17 at 30 mM) and 2,6-DIMEB
(Rs = 1.44 at 20mM); it can be argued that for the enantiosep-
aration of racemic ketoconazole, the methylation at position
O(2) is necessary but not sufficient (2,3-DIMEB and 2-MEB
were ineffective).
The prepared methylated single isomers have remark-
able differences in their solubility and the unique case of
3,6-DIMEB is worth mentioning. The negligible aqueous
solubility of this compound did not allow its screening as
chiral selector under the applied aqueous experimental con-
ditions. This property of 3,6-DIMEB challenges all the pre-
vious reports claiming the enantiodiscrimination ability of
3,6-DIMEB under aqueous conditions. In most cases, when
authors refer in papers to 3,6-DIMEB as the applied chiral
selector, it is in fact a mixture of isomers [18,20]. Among the
per-dimethylated single isomers, 2,6-DIMEB has the highest
aqueous solubility, 2,3-DIMEB possesses intermediate solu-
bility, while 3,6-DIMEB is very slightly soluble in water. The
per-monomethylated derivatives, 2-MEB, 3-MEB, and 6-MEB,
have generally lower aqueous solubility compared to the per-
dimethylated compounds (in some case, almost one order of
magnitude less). 3-MEB has the highest solubility in water,
while 2-MEB and 6-MEB possess remarkably lower solubility.
All the methylated single isomers (and the random com-
posite materials as well) were capable of providing separation
for the stereoisomers (diastereomers and/or enantiomers)
of tapentadol to some extent. The set-ups including TRIMEB
(Rs diast = 10.82, Rs2 = 0.93 at 30 mM) and 2,3-DIMEB
(Rs diast = 11.72, Rs 2 = 1.25 at 30 mM) were performing
particularly efficiently as they could provide simultaneous
separation of one diastereomeric pair (Rs diast) and the later
migrating pair of enantiomers (Rs2). From these results it is
clear that for this opioid drug high DS and a fully methylated
secondary side seems ideal, while methylation on primary
side is of less importance. This observation is in agreement
with our previously published results on the remarkable
enantiorecognition ability of heptakis(2,3-di-O-methyl-6-O-
carboxymethyl)-BCD (HDMCM) towards tapentadol [35].
HDMCM was able to baseline separate both enantiomeric
pairs at high pH values which was attributed to the elec-
trostatic interactions between the negatively charged guests
and the positively charged hosts. Surprisingly, at low pH
C© 2019 The Authors. Electrophoresis published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. www.electrophoresis-journal.com
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Figure 2. Representative CE electropherograms obtained with various methylated -cyclodextrins: (A) 30 mM 2,6-DIMEB, (B) 2.5 mM
2,6-DIMEB, (C) 30 mM RAMEB R©, (D) 30 mM TRIMEB, (E) 10 mM 2-MEB, (F) 30 mM TRIMEB (33.5 cm total and 25 cm effective length and
50 µm id capillary, 20 mM H3PO4-NaOH pH 2.5, 20 kV; 20°C, 200 nm).
value ionic interactions are less predominant, HDMCM was
still able to resolve the later eluting (RS/SR) enantiomeric
pair. Under the light of these results and by taking into con-
sideration the structural similarities between HDMCM and
2,3-DIMEB (both are completely substituted on the secondary
side) it can be argued that, in principle, the 2,3-dimethylated
BCD scaffold is the key factor which governs tapentadol
enantioresolution. An analogue scenario was obtained for
the dapoxetine enantiomers. In this case, the use of a BCD
exclusively methylated on the O(3) positions (3-MEB) already
allowed a satisfactory enantioseparation (Rs = 0.9 at 20 mM);
however, the utilization of the analogue exhaustively methy-
lated on the secondary side (2,3-DIMEB) improved remark-
ably the enantiodiscrimination (Rs = 1.96 at 30 mM) while
the application of the fully methylated counterpart (TRIMEB)
only slightly improved the separation (Rs = 2.02 at 10 mM).
For the separation of the dapoxetine enantiomers, the simul-
taneous and exhaustive methylation of the secondary rim has
a synergistic effect, while methylation on the primary side
has aminor influence. Carvedilol was effectively separated by
bothmethylated compositematerials (all the three tested) and
methylated single isomers. The adrenergic receptor blocker
racemate was best separated by 2-MEB (see Fig. 2E); however,
some resolution was achieved with 6-MEB (Rs = 0.60 at
5mM) and 2,6-DIMEB (Rs = 0.62 at 10mM) as well. Selective
methylation on the O(3) positions seems detrimental for
the discrimination of this pair of enantiomers, as 3-MEB,
2,3-DIMEB, and TRIMEB were completely ineffective.
The methylated BCD selectively substituted on the
primary position, 6-MEB was particularly effective for the
separation of MDPV (Rs = 1.46 at 2 mM), 2-MEB and 3-MEB
showed minor performances (Rs = 0.24 at 2.5 mM and
Rs = 0.52 at 30 mM, respectively), while the remaining
tested CD derivatives (with the exception of CRYSMEB R©)
were ineffective. It seems that a low DS is favorable for the
enantioseparation of this recreational drug.
Flephedrone and mephedrone racemates were best sep-
arated by 2,6-DIMEB (see Fig. 2A) and among the remaining
single methylated isomers only 2-MEB exerted some recog-
nition ability towards flephedrone (Rs = 0.51 at 2.5 mM).
Simultaneous and exhaustive 2,6-methylation seems ideal
for the separation of these synthetic stimulant drugs and
for the separation of primaquine. The antimalarial drug was
only effectively resolved by applying 2,6-DIMEB (Rs = 0.75 at
30 mM) or TRIMEB (Rs = 0.81 at 30 mM). On the other side,
the exhaustive primary side methylation seems unfavorable
for the separation of the alternative antimalarial drug, meflo-
quine as TRIMEB and 6-MEB were the only derivatives not
showing enantiorecognition ability.
Selective methylation on the O(2) seems an important
feature for the effective separation of butylone. TRIMEB (best
performing, Rs = 0.82 at 30 mM), 2,6-DIMEB (Rs = 0.41
at 10 mM), 2,3-DIMEB (Rs = 0.17 at 30 mM), and 2-MEB
(Rs = 0.43 at 5 mM) were effective for partially resolving the
enantiomers of the psychoactive drug.
Single methylated isomers were not effective selectors
for vinpocetine and in this case, the composite methylated
materials outperformed them. However, 2-MEB and 3-MEB
were showing some separation ability (Rs = 0.32 at 5mM and
Rs = 1.15 at 30 mM, respectively). Propranolol was best sepa-
rated by the fully methylated TRIMEB (Rs = 0.31 at 30 mM),
while pantoprazole was successfully resolved by 2-MEB
(Rs = 1.04 at 5mM). For the enantioseparation of terbutaline,
exhaustive substitution on the O(3) seems unfavorable.
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The racemic mixtures of verapamil and tafenoquine
were uniquely separated by the fully methylated TRIMEB
(see Fig. 2F), cetirizine racemate was only and successfully
resolved by applying 2,3-DIMEB, while the enantiomers
of atenolol were effectively separated only by using the
2,6-DIMEB as the chiral selector. Metoprolol, bisoprolol,
vincadifformine, vincamine, 4-methylethcathinone, chlor-
pheniramine, and alogliptin were not separated under the
tested experimental conditions by any of the methylated
BCD derivatives.
To summarize, methylated CDs are effective tools for
chiral separations of different variety of compounds. The
enantiorecognition ability of a chiral selector is difficult to pre-
dict and in most of the cases challenging to rationalize. The
methylated isomeric mixtures are, in general, more versatile
chiral selectors. Taking into account that these derivatives are
easier to prepare and commercially available at a reasonable
price, they could be suggested as first-choice methylated
selectors. However, 2,6-DIMEB showed exceptional enan-
tiorecognition abilities among the single isomers and in
general among the methylated derivatives. The fact that this
derivative is a single component is undoubtedly advantageous
in terms of batch to batch reproducibility, impurity profile
setting, and revealing the detailed mechanism of separation
by NMR spectroscopy to provide a comprehensive theoretical
framework for the underlying mechanisms of enantiomeric
separation. On the other side, the time-consuming synthetic
steps for the 2,6-DIMEB preparation make this compound
less appealing. At this regard, TRIMEB (or even 2-MEB)
could be suggested as valuable alternative. These two single
isomers showed good versatility as chiral selectors, and their
preparation and scale-up were achieved effectively.
3.2 CE characterization of the terbutaline-2,6-DIMEB
host-guest system: Binding constant and
enantiomer migration order determinations
The migration order of the terbutaline enantiomers in the
2,6-DIMEB containing BGE was determined by injecting
terbutaline ‘spiked’ working solution into the electrophoretic
system. Electropherogram in Supporting Information Fig. 1
shows that the R-(-)-terbutaline is the first migrating compo-
nent while S-(+)-terbutaline migrates slower, meaning that
the migration velocity of S-(+)-terbutaline is more affected
by 2,6-DIMEB, also revealing that this isomer has somewhat
higher affinity towards 2,6-DIMEB (Supporting Information
Fig. 1A).
Based on this observation, another CE experiment was
performed aiming the quantification of the association
constants between 2,6-DIMEB and the two terbutaline
enantiomers. 2,6-DIMEB was added at various concentra-
tions (0–1–5–10–15–20–35–40 mM) to the BGE (Supporting
Information Fig. 1B). The increasing concentrations of the
selector resulted in altered migration times of the peaks
of both terbutaline enantiomers. The association constants
were determined by non-linear fitting and were found to be
225 ± 24 for the first migrating R-(-)-terbutaline (Supporting
Information Fig. 2A) and 318 ± 43 for the second migrating
S-(+)-terbutaline (Supporting Information Fig. 2B). The
complex mobility values were found to be the same for both
enantiomers (Supporting Information Fig. 2).
3.3 Structural characterization of the
terbutaline-2,6-DIMEB host-guest
system by NMR
In order to get a deeper insight into themolecular interactions
between the 2,6-DIMEB and terbutaline enantiomers, 1H and
2D ROESY NMR experiments were performed according to
previous works [3, 31]. The enantioselectivity of 2,6-DIMEB
was monitored at acidic pH with racemic terbutaline. In the
1H NMR spectrum of the racemic terbutaline and the 2,6-
DIMEB host, complexation induced chemical shift changes
could be observed for all the non-exchangeable protons of
terbutaline (see Fig. 3).
Spiking the terbutaline-2,6-DIMEB system with enan-
tiopureR-(-)-terbutaline, the1HNMR resonances of the enan-
tiomers could be assigned based on resonance intensity dif-
ferences (see Supporting Information Fig. 3).
2D ROESY NMR spectrum was recorded in order to fur-
ther support the observed interactions between 2,6-DIMEB
and terbutaline at the atomic level. A partial ROESY spectrum
of the terbutaline: 2,6-DIMEB system is shown in Fig. 4. In-
tense cross-peaks can be observed between the aromatic moi-
ety of terbutaline and the inner cavity protons of 2,6-DIMEB,
suggesting that the dihydroxyphenyl ring is fully immersed
into the cavity.
It is worthmentioning that under the same experimental
conditions, this part of the guest molecule does not interact
with the methylated analogue 2,3-DIMEB as clearly shown
by the absence of cross-peaks in the 2D ROESY spectrum
of this system (see Supporting Information Fig. 4 for the
ROESY spectrum). As the resonances of the aromatic moi-
ety show intense cross-peaks exclusively with the inner 2,6-
DIMEB protons H3, H5, and with the protons of the methyl
groups located on the primary rim (CD-(O)6-CH3) and taken
into consideration that the resonances of the tertbutyl moiety
of the guest (protons H10, H11 andH12) show intense cross-
peaks with the protons of the methyl groups located on the
secondary rim (CD-(O)2-CH3) (see Supporting Information
Figs. 5 and 6 for the full ROESY spectrum and the ROESY
enlargement of the methyl protons, respectively), an inclu-
sion arrangement in which the phenyl ring is located at the
proximity of the CD primary interacting with the surround-
ing methoxy groups can be hypothesized. A model for the
inclusion complex of terbutaline and 2,6-DIMEB is schemat-
ically shown in Fig. 5 using key ROESY interactions for the
determination of terbutaline orientation in the cavity.
The arrangementmay also be favoured by the polar inter-
actions between the positively charged secondary amine and
the secondary OH groups of the host.
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Figure 3. The 1H NMR spectrum of racemic terbutaline (blue colour, top) and the 1H NMR spectrum of racemic terbutaline: 2,6-DIMEB
solution at 1:1.5 molar ratio (red, bottom). The latter shows remarkable enantioresolution effects as indicated by *.
Figure 4. Partial 2D ROESY NMR spec-
trum of racemic terbutaline and 2,6-
DIMEB showing intense cross-peaks be-
tween the inner CD protons (H3, H5) and
aromatic protons of terbutaline.
4 Concluding remarks
Herein, we have reported the updated and optimized prepa-
rations of all the methylated single isomer CDs using current
synthetic methodology. Among all developed procedures, the
synthesis of TRIMEB was found to be the most straightfor-
ward: the one step reaction starting from RAMEB R© provided
an easy scale-up and this material can be produced without
difficulties in kg scale. The syntheses of the DIMEB and the
various MEB derivatives require multiple steps and extensive
use of protecting group, and as a consequence the industrial
scale-up is challenging. However, the application of PTC con-
ditions to each alkylating step allowed the production of the
methylated derivatives in multi-gram scale (10–100 g scale).
The complete set of single isomers mono-, di-, and trimethy-
lated derivatives supplemented with the commercially
available randomly substituted analogues were subjected to
a screening experiment in capillary electrophoresis as chiral
selectors. 3,6-DIMEB could not be included in the study
due to aqueous solubility issues. We have concluded that
the isomeric mixtures are in general more versatile chiral
selectors. Among the dimethylated ones, 2,6-DIMEB was
the more versatile in enantioseparation. Terbutaline was
used as a model guest to highlight the role of methylation
pattern in enantiorecognition. 2D ROESY NMR experiments
confirmed that 2-O- and 6-O-methylation extends the cavity
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Figure 5. Proposed geometric arrangement of terbutaline in the
cavity of 2,6-DIMEB, based on the ROESY experiment.
to accommodate terbutaline in an enantiospecific manner.
As an alternative to the single isomer, 2,6-DIMEB, TRIMEB,
or 2-MEB could also provide similar advantages.
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